Navigation Links
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
Date:7/21/2010

apeutics.

About CR845

CR845 is a highly selective, peripherally restricted kappa opioid receptor agonist currently in Phase 2 clinical development for the treatment of postoperative pain.  Randomized, placebo-controlled Phase IIa studies have provided evidence of analgesic efficacy of CR845 administered as a single intravenous dose to women following laparoscopic hysterectomy.  In addition to decreases in reported pain levels, patients receiving CR845 required substantially lower amounts of postoperative opioids for 16 hours, and showed a significant reduction in the incidence of postoperative nausea. Cara expects to complete a Phase 1b repeat dose safety study of CR845 by Q4 this year.  Following this study, the company plans to conduct, a Phase 2b repeat dose efficacy study in laparoscopic hysterectomy patients.  With a total of over 100 human subjects exposed to CR845 to date, there have been no cases of dysphoric reactions or hallucinations as seen previously with centrally-acting kappa opioids.

About Cara Therapeutics

Cara Therapeutics is a privately held biotechnology company focused on developing novel, superior therapeutics to treat pain and inflammation associated with diverse medical conditions. In addition to CR845, Cara's current pipeline includes near-term clinical development candidates within multiple proprietary classes of peripherally restricted cannabinoids with preclinical analgesic and anti-inflammatory activity. Cara also plans to develop entirely novel classes of analgesics that emerge from its proprietary GPCR DimerScreen™ technology.

About Rho Ventures

Founded in 1981, Rho Ventures' multi-stage investing strategy focuses on high-growth companies in large markets that disrupt traditional value chains. Rho Ve
'/>"/>

SOURCE Cara Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... Award for Vision, Innovation, and Leadership has been awarded to ... award recognizes an individual who has had a significant impact ... for several decades. "I am honored to ... Peltz , Ph.D., CEO of PTC Therapeutics, Inc. "When I ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
(Date:11/23/2014)... (PRWEB) November 23, 2014 AngelWeddingDress.com ... worldwide a new selection of beach wedding dresses. “If ... best prices, visit AngelWeddingDress.com as soon as possible. Here ... workmanship.” The sales manager says. , Holding a big ... girl. And choosing a beautiful beach wedding dress is ...
(Date:11/23/2014)... 23, 2014 Syngenta lawsuits are now ... of farmers and agribusinesses that have allegedly incurred significant ... Agrisure Viptera and Agrisure Duracade, genetically modified (GMO) ... for sale in China. According to a report from ... ban U.S. corn imports. Because China is the third-largest ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Every year ... their communities. AlignLife experience rapid growth in the Greenville, ... very unique opportunity. AlignLife of Simpsonville will ... offices for their first annual Toy Drive. These six ... they would support with this year's toy drive. With ...
(Date:11/22/2014)... UWDress.com, a successful wedding dress shop, has released its new ... to prepare for the wedding season. All of them are ... UWDress.com is a reliable company that has many years of ... -- formal wedding guest attire. This new collection comes in ... princess. As one of the leading companies in the wedding ...
(Date:11/22/2014)... 23, 2014 Today, Dylan Queen, a ... collection of wedding dresses; the business offers a wide ... accessories for ladies worldwide, allowing them to create multiple ... the company, this new collection of chic wedding dresses ... they are offered at discounted rates now. Dylan Queen ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:Formal Wedding Guest Attire Added to UWDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... EBITDA Quarter in Q3 2009PURCHASE, N.Y., May 12 ... developer and marketer of nutritional supplements under the Iceland ... manage blood sugar levels, improve cardiovascular health, enhance memory ... for the third quarter and the first nine months ...
... in email and file archiving solutions for ... management, today announces the release of the ... the award-winning MessageSolution Enterprise Email Archive at ... MessageSolution,s SaaS email archiving solution supports ...
... CCHIT recognizes its functionality; CureMD EHR v10 CCHIT 08 Certified ... ... May 12, 2009 -- The Certification Commission for Healthcare Information ... updated interoperability requirements, is a conditionally CCHIT Certified® 08 Ambulatory ...
... beneficiaries are more satisfied with their health care, and ... Americans with employer-sponsored insurance (ESI), according to a study ... Health Affairs Web site. , The study ... Biennial Health Insurance Survey, a nationally representative survey of ...
... Chemical Entity for Topical Acne Treatment in a DecadeCARLSBAD, Calif., ... has entered into a co-promotion agreement with Allergan for ... vulgaris. Representing the first new molecule in a decade approved ... patients 12 years of age and older, ACZONE(R) Gel 5% ...
... 11 Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) ... of shares of common stock at $1.25 per share and ... offering to a single institutional investor. The Company currently expects ... hand and/or cash received in connection with this offering to ...
Cached Medicine News:Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 2Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 3Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 4Health News:MessageSolution Releases SaaS Hosted Archiving Solution at Microsoft TechEd North America 2009 5Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 2Health News:Doctors Love its Usability & CCHIT Recognizes its Functionality; CureMD EHR v10 CCHIT 08 Certified 3Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 2Health News:Elderly Medicare beneficiaries give their coverage higher ratings than do those with ESI 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 2Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 3Health News:SkinMedica to Co-Promote ACZONE(R) (dapsone) Gel 5% to Pediatricians in the U.S. 4Health News:Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $20 Million of Common Stock and Warrants 2
This fume hood features a one-piece shell molded of polyethylene with a clear acrylic panel that slides on inside tracks. It can be set in an open, closed or intermediate position....
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... Microtome is ideal for sectioning of specimens in ... Specimen rise is automatic and accurate with section ... increments of 2 microns. Will accommodate MNL ... Vibratomes Freezing Stages , ...
... Gold Package is the ultimate ... package includes the Vibratome 3000 ... starter package accessory kit, additional ... mounts 1/2" head, rotating stage, ...
Medicine Products: